Polymorphic variants in alpha-methylacyl-CoA racemase and prostate cancer.

Prostate 2007 Oct;67(14):1487-97

Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland, USA.

Background: Alpha-methylacyl-CoA racemase (AMACR), which prepares branched chain fatty acids to be metabolized for energy and is implicated in the activation of the COX-inhibiting form of ibuprofen, is overexpressed in prostate cancer and its precursor lesions. Significant differences in AMACR allele frequencies have been reported for hereditary prostate cancer (HPC), but the relevance of AMACR in the context of its substrates have not been studied.

Methods: We conducted a nested case-control study of 1,318 prostate cancer cases and 1,842 controls from the screening arm of the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial. Five non-synonymous (nsSNP) and two intronic AMACR polymorphisms were genotyped. Conditional logistic regression models were used to evaluate the associations between the genetic variants and prostate cancer.

Results: Overall, prostate cancer was not related to AMACR gene variants; however, risks for prostate cancer were significantly reduced among regular ibuprofen users who carried allele variants at four nsSNP loci (M9V, D175G, S201L, and K277E; all P(trend) < 0.05) or carried the TGTGCG haplotype (OR = 0.65; 95% CI 0.44-0.97). No AMACR-related associations were noted among nonregular ibuprofen users (all P(interaction) > 0.33).

Conclusion: AMACR gene variants were unrelated to prostate cancer overall in this study. The protective associations observed among ibuprofen users suggest that AMACR gene variants may enhance the chemopreventive effects of ibuprofen on prostate cancer risk.

Download full-text PDF

Source
http://dx.doi.org/10.1002/pros.20635DOI Listing
October 2007
17 Reads

Publication Analysis

Top Keywords

prostate cancer
32
gene variants
12
amacr gene
12
ibuprofen users
12
prostate
10
cancer
9
alpha-methylacyl-coa racemase
8
amacr
7
variants
5
ibuprofen
5
genetic variants
4
variants prostate
4
regular ibuprofen
4
associations genetic
4
models evaluate
4
evaluate associations
4
prostate cancerresults
4
cancerresults prostate
4
risks prostate
4
regression models
4

References

(Supplied by CrossRef)

Jiang et al.
Am J Surg Pathol 2001

Luo et al.
Cancer Res 2002

Rubin et al.
JAMA 2002

Zhou et al.
Am J Surg Pathol 2002

Zha et al.
Cancer Res 2003

Zheng et al.
Cancer Res 2002

Leitzmann et al.
Cancer Epidemiol Biomarkers Prev 2002

Platz et al.
Cancer Epidemiol Biomarkers Prev 2005

Nelson et al.
Oncol Rep 2000

Habel et al.
Cancer Causes Control 2002

Perron et al.
Int J Cancer 2003

Similar Publications